Qilian International Holding Group Limited Receives Approval for the Sale of its Newly Developed Nitrofurantoin Enteric-coated Tablets

/PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company", "Qilian International", "we", "our" or "us"), a China-based...

Related Keywords

China ,Qilian ,Gansu ,Jiuquan ,Chinese ,Zhanchang Xin ,Tina Xiao ,Inspection Center ,Gansu Provincial Drug Administration ,Ascent Investors Relations ,National Essential Medicines List ,Qilian International Holding Group ,National Reimbursement Drug List ,Qilian International ,Gansu Provincial Drug Administration On ,Prnewswire Qilian International Holding Group Limited Nasdaq ,Gansu Provincial Institute Of Drug Inspection ,International Holding Group Limited ,Gansu Province ,Gansu Provincial Drug ,Good Manufacturing Practice ,Gansu Provincial Institute ,Private Securities Litigation Reform Act ,International Holding Group ,Qilian International Holding Group Limited ,Biotechnology ,Health Care Amp Hospitals ,Pharmaceuticals ,Medical Pharmaceuticals ,International Medical Approval ,